* ICU Medical Inc ICUI.OQ ICUI.O is expected to show a
fall in
quarterly revenue when it reports results
* The San Clemente California-based company is expected to
report
a 2.8% decrease in revenue to $565.75 million from $582.08
million a year ago, according to the mean estimate from 2
analysts, based on LSEG data.
* Refinitiv's mean analyst estimate for ICU Medical Inc is
for
earnings of $1.39 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for ICU Medical
Inc
is $200, above its last closing price of $102.59.
This summary was machine generated November 4 at 03:05 GMT. All
figures in US dollars unless otherwise stated